目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global human vaccine market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global human vaccine market 2018 - 2022 ($ billion)
4.2 Route of Administration Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration
6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Intramuscular - Market size and forecast 2023-2028
Exhibit 34: Chart on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Intramuscular - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Intramuscular - Year-over-year growth 2023-2028 (%)
6.4 Subcutaneous - Market size and forecast 2023-2028
Exhibit 38: Chart on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Subcutaneous - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Subcutaneous - Year-over-year growth 2023-2028 (%)
6.5 Oral - Market size and forecast 2023-2028
Exhibit 42: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Route of Administration
Exhibit 46: Market opportunity by Route of Administration ($ billion)
Exhibit 47: Data Table on Market opportunity by Route of Administration ($ billion)

7 Market Segmentation by End-user
7.1 Market segments
Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 50: Chart on Comparison by End-user
Exhibit 51: Data Table on Comparison by End-user
7.3 Pediatrics - Market size and forecast 2023-2028
Exhibit 52: Chart on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Pediatrics - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Pediatrics - Year-over-year growth 2023-2028 (%)
7.4 Adults - Market size and forecast 2023-2028
Exhibit 56: Chart on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Adults - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Adults - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ billion)
Exhibit 61: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Astellas Pharma Inc.
Exhibit 111: Astellas Pharma Inc. - Overview
Exhibit 112: Astellas Pharma Inc. - Product / Service
Exhibit 113: Astellas Pharma Inc. - Key news
Exhibit 114: Astellas Pharma Inc. - Key offerings
12.4 AstraZeneca Plc
Exhibit 115: AstraZeneca Plc - Overview
Exhibit 116: AstraZeneca Plc - Product / Service
Exhibit 117: AstraZeneca Plc - Key news
Exhibit 118: AstraZeneca Plc - Key offerings
12.5 Bavarian Nordic AS
Exhibit 119: Bavarian Nordic AS - Overview
Exhibit 120: Bavarian Nordic AS - Product / Service
Exhibit 121: Bavarian Nordic AS - Key offerings
12.6 Bharat Biotech Ltd.
Exhibit 122: Bharat Biotech Ltd. - Overview
Exhibit 123: Bharat Biotech Ltd. - Product / Service
Exhibit 124: Bharat Biotech Ltd. - Key news
Exhibit 125: Bharat Biotech Ltd. - Key offerings
12.7 CSL Ltd.
Exhibit 126: CSL Ltd. - Overview
Exhibit 127: CSL Ltd. - Business segments
Exhibit 128: CSL Ltd. - Key offerings
Exhibit 129: CSL Ltd. - Segment focus
12.8 Daiichi Sankyo Co. Ltd.
Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 131: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
12.9 Emergent BioSolutions Inc.
Exhibit 134: Emergent BioSolutions Inc. - Overview
Exhibit 135: Emergent BioSolutions Inc. - Product / Service
Exhibit 136: Emergent BioSolutions Inc. - Key news
Exhibit 137: Emergent BioSolutions Inc. - Key offerings
12.10 GlaxoSmithKline Plc
Exhibit 138: GlaxoSmithKline Plc - Overview
Exhibit 139: GlaxoSmithKline Plc - Business segments
Exhibit 140: GlaxoSmithKline Plc - Key news
Exhibit 141: GlaxoSmithKline Plc - Key offerings
Exhibit 142: GlaxoSmithKline Plc - Segment focus
12.11 Inovio Pharmaceuticals Inc.
Exhibit 143: Inovio Pharmaceuticals Inc. - Overview
Exhibit 144: Inovio Pharmaceuticals Inc. - Product / Service
Exhibit 145: Inovio Pharmaceuticals Inc. - Key news
Exhibit 146: Inovio Pharmaceuticals Inc. - Key offerings
12.12 Merck and Co. Inc.
Exhibit 147: Merck and Co. Inc. - Overview
Exhibit 148: Merck and Co. Inc. - Business segments
Exhibit 149: Merck and Co. Inc. - Key news
Exhibit 150: Merck and Co. Inc. - Key offerings
Exhibit 151: Merck and Co. Inc. - Segment focus
12.13 Mitsubishi Chemical Group Corp.
Exhibit 152: Mitsubishi Chemical Group Corp. - Overview
Exhibit 153: Mitsubishi Chemical Group Corp. - Business segments
Exhibit 154: Mitsubishi Chemical Group Corp. - Key offerings
Exhibit 155: Mitsubishi Chemical Group Corp. - Segment focus
12.14 Moderna Inc.
Exhibit 156: Moderna Inc. - Overview
Exhibit 157: Moderna Inc. - Product / Service
Exhibit 158: Moderna Inc. - Key offerings
12.15 Pfizer Inc.
Exhibit 159: Pfizer Inc. - Overview
Exhibit 160: Pfizer Inc. - Product / Service
Exhibit 161: Pfizer Inc. - Key news
Exhibit 162: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 163: Sanofi SA - Overview
Exhibit 164: Sanofi SA - Business segments
Exhibit 165: Sanofi SA - Key news
Exhibit 166: Sanofi SA - Key offerings
Exhibit 167: Sanofi SA - Segment focus
12.17 Serum Institute of India Pvt. Ltd.
Exhibit 168: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 169: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 170: Serum Institute of India Pvt. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 173: Currency conversion rates for US$
13.4 Research methodology
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
13.5 List of abbreviations
Exhibit 177: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global human vaccine market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits31: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Intramuscular - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Intramuscular - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Subcutaneous - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Subcutaneous - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Route of Administration ($ billion)
Exhibits47: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits48: Chart on End-user - Market share 2023-2028 (%)
Exhibits49: Data Table on End-user - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by End-user
Exhibits51: Data Table on Comparison by End-user
Exhibits52: Chart on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Pediatrics - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Pediatrics - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Adults - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Adults - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by End-user ($ billion)
Exhibits61: Data Table on Market opportunity by End-user ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Astellas Pharma Inc. - Overview
Exhibits112: Astellas Pharma Inc. - Product / Service
Exhibits113: Astellas Pharma Inc. - Key news
Exhibits114: Astellas Pharma Inc. - Key offerings
Exhibits115: AstraZeneca Plc - Overview
Exhibits116: AstraZeneca Plc - Product / Service
Exhibits117: AstraZeneca Plc - Key news
Exhibits118: AstraZeneca Plc - Key offerings
Exhibits119: Bavarian Nordic AS - Overview
Exhibits120: Bavarian Nordic AS - Product / Service
Exhibits121: Bavarian Nordic AS - Key offerings
Exhibits122: Bharat Biotech Ltd. - Overview
Exhibits123: Bharat Biotech Ltd. - Product / Service
Exhibits124: Bharat Biotech Ltd. - Key news
Exhibits125: Bharat Biotech Ltd. - Key offerings
Exhibits126: CSL Ltd. - Overview
Exhibits127: CSL Ltd. - Business segments
Exhibits128: CSL Ltd. - Key offerings
Exhibits129: CSL Ltd. - Segment focus
Exhibits130: Daiichi Sankyo Co. Ltd. - Overview
Exhibits131: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits132: Daiichi Sankyo Co. Ltd. - Key news
Exhibits133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits134: Emergent BioSolutions Inc. - Overview
Exhibits135: Emergent BioSolutions Inc. - Product / Service
Exhibits136: Emergent BioSolutions Inc. - Key news
Exhibits137: Emergent BioSolutions Inc. - Key offerings
Exhibits138: GlaxoSmithKline Plc - Overview
Exhibits139: GlaxoSmithKline Plc - Business segments
Exhibits140: GlaxoSmithKline Plc - Key news
Exhibits141: GlaxoSmithKline Plc - Key offerings
Exhibits142: GlaxoSmithKline Plc - Segment focus
Exhibits143: Inovio Pharmaceuticals Inc. - Overview
Exhibits144: Inovio Pharmaceuticals Inc. - Product / Service
Exhibits145: Inovio Pharmaceuticals Inc. - Key news
Exhibits146: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits147: Merck and Co. Inc. - Overview
Exhibits148: Merck and Co. Inc. - Business segments
Exhibits149: Merck and Co. Inc. - Key news
Exhibits150: Merck and Co. Inc. - Key offerings
Exhibits151: Merck and Co. Inc. - Segment focus
Exhibits152: Mitsubishi Chemical Group Corp. - Overview
Exhibits153: Mitsubishi Chemical Group Corp. - Business segments
Exhibits154: Mitsubishi Chemical Group Corp. - Key offerings
Exhibits155: Mitsubishi Chemical Group Corp. - Segment focus
Exhibits156: Moderna Inc. - Overview
Exhibits157: Moderna Inc. - Product / Service
Exhibits158: Moderna Inc. - Key offerings
Exhibits159: Pfizer Inc. - Overview
Exhibits160: Pfizer Inc. - Product / Service
Exhibits161: Pfizer Inc. - Key news
Exhibits162: Pfizer Inc. - Key offerings
Exhibits163: Sanofi SA - Overview
Exhibits164: Sanofi SA - Business segments
Exhibits165: Sanofi SA - Key news
Exhibits166: Sanofi SA - Key offerings
Exhibits167: Sanofi SA - Segment focus
Exhibits168: Serum Institute of India Pvt. Ltd. - Overview
Exhibits169: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits170: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations